Actively Recruiting
Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
Led by The University of Texas Health Science Center, Houston · Updated on 2026-05-14
120
Participants Needed
1
Research Sites
210 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.
CONDITIONS
Official Title
Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient undergoing minimally invasive myomectomy with either a single intramural or submucosal fibroid 5 cm or larger
- Patients undergoing minimally invasive myomectomy with 5 or more fibroids
You will not qualify if you...
- Pregnancy
- Age under 18 years
- Patients undergoing concomitant surgery such as endometriosis surgery
- Suspected malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
R
Randa Jalloul, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here